Article
The Promise of TKIs
TKIs are small molecules that can act intracellularly to inhibit multiple pathways involved in the pathogenesis of retinal diseases and when combined with the appropriate sustained delivery platform may offer a more durable treatment approach, ultimately reducing the treatment burden for patients.